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ABSTRACT
The function of a conserved PDS95/DLG1/ZO1 (PDZ) binding motif (E6 PBM) 
at the C-termini of E6 oncoproteins of high-risk human papillomavirus (HPV) types 
contributes to the development of HPV-associated malignancies. Here, using a primary 
human keratinocyte-based model of the high-risk HPV18 life cycle, we identify a 
novel link between the E6 PBM and mitotic stability. In cultures containing a mutant 
genome in which the E6 PBM was deleted there was an increase in the frequency 
of abnormal mitoses, including multinucleation, compared to cells harboring the 
wild type HPV18 genome. The loss of the E6 PBM was associated with a significant 
increase in the frequency of mitotic spindle defects associated with anaphase and 
telophase. Furthermore, cells carrying this mutant genome had increased chromosome 
segregation defects and they also exhibited greater levels of genomic instability, as 
shown by an elevated level of centromere-positive micronuclei. In wild type HPV18 
genome-containing organotypic cultures, the majority of mitotic cells reside in the 
suprabasal layers, in keeping with the hyperplastic morphology of the structures. 
However, in mutant genome-containing structures a greater proportion of mitotic 
cells were retained in the basal layer, which were often of undefined polarity, thus 
correlating with their reduced thickness. We conclude that the ability of E6 to target 
cellular PDZ proteins plays a critical role in maintaining mitotic stability of HPV 
infected cells, ensuring stable episome persistence and vegetative amplification.
INTRODUCTION
Of the more than 200 human papillomavirus (HPV) 
types that are known to infect humans, twelve have been 
defined as human carcinogens (HPV16, 18, 31, 33, 35, 
39, 45, 51, 52, 56, 58 and 59), with another twelve types 
that are closely related to the carcinogenic viruses, defined 
as “probably” or “possibly carcinogenic” [1]. These so-
called high-risk (HR) viruses are closely associated with 
the development of epithelial cancers of the anogenital and 
oropharyngeal tracts [2–4]. The continuous expression of 
the HPV early proteins E6 and E7 is one of the defining 
features of HPV driven carcinogenesis and thus, they are 
attractive targets for therapeutic intervention of these 
tumours. The ability of E6 and E7 proteins to deregulate 
host mechanisms of cell cycle control, senescence and 
survival can lead to cellular immortalization, and the 
development of genetically unstable cells that are at 
increased risk of oncogenic transformation [5]. The key 
biological activities of the E6 oncoprotein that contribute 
to carcinogenesis include the capacity to inactivate the 
p53 tumor suppressor protein, activation of telomerase 
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and the targeting of specific cellular proteins containing 
PDZ (PSD95/DLG1/ZO-1) domains (referred to as PDZ 
proteins) [6].
Binding between PDZ proteins and E6 is mediated 
by a C-terminal class I PDZ domain-binding motif (PBM) 
that is only found in E6 proteins of the HR-HPV types, 
suggesting that the motif acts as an oncogenic signature. 
Indeed, the E6 PBM was shown to be necessary for 
the morphological transformation and the induction of 
tumorigenesis of rodent cell lines [7]. Moreover, in a 
transgenic mouse model of cervical carcinogenesis, the 
presence of the HPV16 E6 PBM function enhanced tumor 
development, affecting both tumor size and area of tumor 
invasion [8]. In mammalian keratinocytes, the E6 motif 
has been linked to cell proliferation [9, 10] and whilst not 
necessary for the immortalization of these cells, it has been 
shown to contribute to epithelial-mesenchymal transition 
and anchorage–independent cell growth; two acquired 
phenotypes that are linked to invasive and metastatic 
growth of tumors [11–14].
The interaction between E6 and PDZ proteins most 
often leads to ubiquitin-mediated degradation of the host 
protein via the proteasome [15], although this is not the 
case for all PDZ targets [16, 17]. Phosphorylation of the E6 
PBM has been shown to negatively regulate the interaction 
with PDZ protein partners and confers the ability of the 
E6 protein to interact with a number of 14-3-3 isoforms 
[18, 19]. Many of the PDZ proteins that associate with E6 
have roles in governing cell polarity, including apico-basal 
epithelial polarity and asymmetric cell division. In fact, 
core components of all the apico-basal polarity modules 
(Crumbs, Par and Scribble) are targets of the E6 domain. 
These include PALS1-associated tight junction protein 
(PATJ) of the Crumbs complex [20], PDZ portioning 
defective 3 protein (PAR3) of the Par complex [16] and the 
human homologues of the Drosophila tumor suppressor 
proteins, discs large 1 (DLG1) and scribble (hSCRIB), 
both of the Scribble complex [7, 15, 21, 22]. Other PDZ 
targets of E6 include members of the MAGI family of 
proteins, which are also linked to polarity [23, 24], and the 
non-receptor tyrosine phosphatases PTPN3 and PTPN13, 
that both have roles in regulating signal transduction 
pathways involved in cell proliferation, apoptosis, 
migration and intracellular trafficking [25, 26].
The function of the E6 PBM has been shown to play 
an essential role in the replication cycle of HR-HPV types. 
Our studies using organotypic raft cultures of primary 
human foreskin keratinocytes (HFK) transfected with a 
mutant HPV18 genome which expresses an E6 protein 
lacking the PBM (E6ΔPDZ), showed a deleterious effect 
of loss of this E6 function upon the productive phase (viral 
episome amplification and viral late gene expression) 
of the virus life cycle [27]. Further analysis of these 
cultures demonstrated that the defect in the productive 
cycle was linked to a reduction in cell proliferation in the 
upper layers of the stratified cultures. Both viral episome 
establishment and stable maintenance of the viral episomes 
were also compromised upon monolayer cell growth of 
the basal-like undifferentiated cells [27], observations that 
were supported by investigations of other HR-HPV types 
[28, 29]. Collectively, these studies indicate that the E6 
PBM is critical for multiple stages of the infectious cycle 
of cancer–causing HPV types.
In this study, we have investigated in greater detail 
the impact of loss of the E6 PBM function on the growth 
of viral genome-containing keratinocytes. We show 
that this function of E6 is strongly associated with the 
maintenance of mitotic stability of episome-containing 
cells. In the absence of the E6 PBM, cells develop severe 
mitotic abnormalities and accrue genomic instability. 
Thus, this function of E6 is vital for episome maintenance 
and vegetative replication, potentially by acting to 
safeguard mitotic integrity of HPV-infected cells.
RESULTS
As described previously, we genetically engineered 
the wild type (WT) HPV18 genome to replace codons at 
positions 155 and 156 of the E6 protein with translation 
termination codons, creating the mutant genome E6ΔPDZ 
[27]. Thus, the E6 protein expressed from the mutant 
genome lacked the C-terminal four amino acids constituting 
the PBM (155ETQV158). The deletion of the HPV18 E6 PBM 
negates the targeting of PDZ proteins but does not interfere 
with other E6 functions, including the ability of the E6 
protein to degrade the p53 tumor suppressor protein [27]. 
We established HPV18 genome-containing cell lines by 
transfecting primary human foreskin keratinocytes (HFK) 
from three different donors (#1, #2 and #3) with the WT 
genome or the mutant genome. Both the WT and E6ΔPDZ 
genomes replicated as extrachromosomal plasmids in 
these cells (Figure 1A); although E6ΔPDZ was present at 
reduced copy number in comparison to the WT episomes, 
in agreement with our previous findings [27]. Notably, the 
E6ΔPDZ mutation does not adversely affect the levels of 
the E6, or the E7 proteins expressed in the HPV18 genome-
containing cells grown in undifferentiated monolayer 
culture or in organotypic raft culture [27].
Since extended cell culture of E6ΔPDZ cell 
lines often leads to a sharp reduction in maintenance 
of episomes and viral DNA integration [27], only cell 
passages (≤ 35 cell population doublings) prior to these 
viral genetic events (as determined by Southern analysis) 
were used in this study.
Deletion of the E6 PBM is associated with 
enhanced frequency of nuclear atypia of HPV18 
genome-containing cells
By using bright-field microscopy, it was noticeable 
that in monolayer cell growth conditions, in comparison to 
the untransfected donor HFK, both the WT and E6ΔPDZ 
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genome-containing cell cultures were characterized by 
the presence of cells with multiple, and often misshapen 
nuclei (Figure 1B). Quantification of HFK cells showed 
that 0.43% of cells had this aberrant multinucleated 
morphology (≥ 3 nuclei/cell), whereas the percentage of 
multinucleated cells increased by 7-fold in WT genome 
containing cells (3.15%) (Figure 1C). Interestingly, 
multinucleation of cells harboring the E6ΔPDZ genomes 
was enhanced further (17-fold change; 7.47% of cells) 
(Figure 1C). Furthermore, cells containing the E6ΔPDZ 
genomes showed a 2-fold increase in frequency of cells 
with high levels of multinucleation (≥ 5 nuclei/cell) in 
comparison to those carrying the WT genomes, increasing 
from 1.61% (WT) to 3.26% (E6ΔPDZ). These data 
demonstrate that the replication of HR-HPV episomes 
in primary keratinocytes leads to perturbation of cell 
division, in agreement with previous suggestions [30–32]. 
Moreover, our analysis also suggests that loss of the E6 
PDZ binding function further increases the deleterious 
effect of the virus on coordinated cell division.
Live cell microscopy reveals an increase in 
frequency of cells undergoing abnormal mitosis 
in E6ΔPDZ cell cultures
To investigate whether the increase in 
multinucleated cells observed upon loss of the E6 PBM 
was due to increased mitotic errors, we next examined 
mitotic progression of the cells by live cell imaging of 
asynchronous monolayer cell cultures. Cells carrying 
either WT or E6ΔPDZ genomes were plated at low cell 
density and once individual cell colonies were visible they 
were imaged for 16 h by phase contrast microscopy, using 
the Cell-IQ system. The resulting time-lapse movies were 
subsequently analyzed to determine the number of mitotic 
events within individual colonies, and each mitotic event 
classified as ‘normal’ or ‘abnormal’ according to defined 
criteria (e.g. time taken from mitotic entry to daughter 
cell separation, mitotic spindle polarity, visible and 
equal separation of condensed chromosomes). Images of 
representative examples of normal and abnormal mitotic 
Figure 1: Loss of E6 PBM function is associated with enhanced frequency of nuclear atypia of viral genome-containing 
cells. A. Southern analysis confirmed presence of HPV18 wild type (WT) and mutant (E6ΔPDZ) episomes migrating as supercoils (SC) 
and open circles (OC) in cells; the mutant genomes establish at a lower copy number than the WT genomes as shown previously (the images 
of the two lanes were taken from the same Southern blot at a single exposure) [27]. B. Phase contrast images of cells grown in monolayer 
culture, including untransfected donor cells (HFK), with fibroblast feeder cells (F). HPV18 genome-containing cells showing nuclear atypia 
(multinucleation) are identified (black dotted line). C. Bar graph, percentage of cells containing multiple nuclei; data (mean ± standard 
error of the mean) derived from random fields of view and cells from three independent donors. Student t test was used to determine the 
significance (**, P<0.01; ***, P<0.001; ****, P<0.0001). Total number of cells counted: HFK, 2000 cells; WT, 1400 cells; E6ΔPDZ, 1060 
cells.
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cell divisions are given in Figure 2A and 2B respectively, 
and movies are shown in Supplementary Figure S1. In 
order to eliminate any donor keratinocyte effects, the 
analysis was performed on cell lines established in the 
three different keratinocyte backgrounds.
The distributions of normal and abnormal mitoses 
in the HPV18 genome–containing cells are shown in 
Figure 2C. The majority of mitotic cells carrying the 
WT genomes underwent normal cell division, with less 
than 25% (a range of 14.5% to 24.6% between the three 
donors) undergoing an aberrant division. However, in 
cells carrying the E6ΔPDZ genomes, the proportion of 
mitotic cells undergoing abnormal cell division increased 
markedly across all three donors (a range of 45.5% 
to 60.8%). Moreover, we also noted that in E6ΔPDZ-
containing cell lines, even cells with elevated numbers 
of nuclei (>15) entered mitotic division (Supplementary 
Figure S2). In the examples given in Figure 2A, the time 
to complete a normal bipolar mitotic division for both 
WT and E6ΔPDZ genome-containing cells is just over 
1 h, with no noticeable differences in the time taken 
to complete mitosis between cell lines. However, the 
abnormal WT and E6ΔPDZ divisions are multi-radial and 
time to completion is extended to over 1 h 45 min (Figure 
2B). Taken together, these data indicate that in the context 
of whole HR-HPV genomes, loss of E6 PBM function is 
associated with an increase in the frequency of abnormal 
mitotic events.
Loss of E6 PBM function is associated with an 
increase in spindle-associated abnormalities in 
late stage mitosis
Next, we wanted to further characterize the mitotic 
defect observed in the E6ΔPDZ genome-containing 
cells. Therefore, cells were grown in monolayer cell 
culture on glass coverslips, fixed and stained for the 
mitotic spindle protein alpha-tubulin and counterstained 
with the DNA dye DAPI. As before, mitotic cells were 
scored from random fields of view as to whether ‘normal’ 
or ‘abnormal’; the specific events were chromosome 
alignment on spindle and spindle polarity in metaphase; 
successful separation of chromosomes, spindle polarity 
in anaphase and telophase, the presence of anaphase or 
telophase bridges, and telophase spindle polarity.
Both WT and E6ΔPDZ cells were identified in 
prophase, metaphase, anaphase and telophase in all 
three individual donor backgrounds. In agreement with 
the findings from the live microscopy analysis (Figure 
2), increased abnormal mitoses were observed in cells 
harboring the mutant E6ΔPDZ genomes (data not 
shown). Unlike the normal mitotic cells, which were 
mainly in anaphase-telophase, the majority of abnormal 
mitotic WT and E6ΔPDZ genome-containing cells were 
in metaphase (Figure 3A). Moreover, whilst very few of 
the cells carrying WT genomes had defects in anaphase 
and telophase, in comparison, the proportion of E6ΔPDZ 
cells with spindle abnormalities in both anaphase and 
telophase increased in all three donors (Figure 3A, i, and 
3B). Thus, in donor #1, abnormalities in anaphase and 
telophase of E6ΔPDZ genome-containing cells increase 
by 2.7-fold, in donor #2 by 5.6-fold and in donor #3 by 
3.0-fold, compared to cells harboring the WT genomes. 
These data suggest that whilst only a small proportion 
of cells harboring WT HPV18 genomes with metaphase 
abnormalities are able to progress through the mitotic 
cycle, a greater proportion of abnormal cells containing 
the mutant genome are able to move into anaphase and 
telophase. Examples of mitotic abnormalities detected in 
the HPV18 genome-containing cells are shown in Figure 
3B.
To further define the underlying defects occurring 
in anaphase and telophase in the E6ΔPDZ cells, we next 
analyzed the frequency of specific mitotic abnormalities 
in anaphase (anaphase bridges, lagging chromosomes, 
spindle polarity) and telophase (spindle polarity, telophase 
bridge) (see Figure 3B for examples of these defects in 
E6ΔPDZ cells). From this analysis, it was shown that 
there was increased frequency of defects associated with 
anaphase and telophase in E6ΔPDZ genome-containing 
cells compared to the WT genome controls (Figure 3C). 
Indeed, the combined frequency of these abnormalities 
was statistically significant (p<0.05) relative to the cells 
harboring the WT genomes, although the difference in the 
frequency of any one abnormality did not reach statistical 
significance (Figure 3C and 3D). Together, these data 
suggest that loss of the E6 PBM function is linked to a 
spindle abnormality in the viral episome-containing cells 
and not a signaling defect associated with one specific 
mitotic abnormality. In conclusion, in HPV18 genome-
containing cells, the loss of E6 PDZ binding resulted in a 
quantitative increase in mitotic defects persisting late into 
mitosis.
Increased frequency of centromere-positive 
micronuclei in E6ΔPDZ genome-containing cells
Our findings that loss of the E6 PBM function led 
to an increase in the frequency of spindle abnormalities in 
anaphase and telophase suggested that cells harboring the 
E6ΔPDZ genomes would exhibit increased chromosome 
segregation defects. One consequence of these is the 
partition of chromosomes into micronuclei, whereby 
nuclear membranes form around lagging chromosomes 
and are visible in interphase cells as discrete extra-
nuclear formations of enveloped DNA. Therefore, to 
investigate this possibility, the frequency of cells with 
micronuclei was determined in cells harboring the HPV18 
genomes (Figure 4A). Micronuclei were observed in 
cells replicating either WT or E6ΔPDZ genomes, but 
the frequency of cells with micronuclei increased in the 
presence of E6ΔPDZ genomes (1.3 – 2.9 fold increase 
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Figure 2: Live cell microscopy shows that loss of E6 PBM function is associated with an increase in abnormal mitoses 
in viral genome-containing cells. Examples of normal A. and abnormal B. mitoses from the live cell microscopy in cell lines harboring 
the WT or the E6ΔPDZ genomes (movies given in Supplementary Figure S1). Cells undergoing mitosis are identified with a white arrow 
and the time to complete mitosis is given. Note that in these examples of abnormal mitosis, the event is multipolar and the time taken to 
completion is much longer than for completion of normal cell division. C. Bar graph, percentage of mitoses that were normal or abnormal 
in each of the three donor backgrounds. Mitoses defined as normal if bipolar, had visible and equal separation of condensed chromatin and 
the time to completion of mitosis was not excessive; otherwise the mitotic event was scored as abnormal. Number of colonies counted was 
in the range of 14 to 23 and for each of the cell lines between 90-308 mitoses counted.
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compared to WT genome-containing cells), although 
these increases only reached significance in two out of the 
three donors analyzed. These data therefore support our 
previous conclusion that the loss the E6 PBM function 
enhances the dysfunction of the mitotic apparatus.
Since micronuclei formation occurred in the 
presence of WT as well as the mutant genomes, it was 
important to establish if they arose through similar 
mechanisms. Micronuclei may arise from both 
chromosome segregation errors to give centromere-
positive micronuclei; or through failed separation of 
chromosome fragments to produce centromere-negative 
micronuclei. Therefore, cells were stained with an 
antibody that detects the centromere protein, centromere 
protein A (CENPA) and micronuclei were then scored 
as CENPA-positive or –negative (Figure 4B). In both 
Figure 3: Loss of E6 PBM function leads to an enhancement in the frequency of abnormal cells progressing into 
anaphase and telophase. A. Abnormal (bar graph i) or normal (bar graph ii) mitoses were scored in each stage of mitosis (prophase, 
metaphase, anaphase and telophase) by α-tubulin staining and counterstaining with DAPI. The data are derived from three independent 
experiments for each of the three donors and presented as a proportion of total abnormal (top graph) or normal (bottom graph) mitoses. 
For each experiment, a minimum of 200 cells per donor was counted. B. Examples of abnormal mitoses in HPV18 genome-containing 
cells showing spindle morphology (α-tubulin, green) and chromosomes (DAPI, blue). C. Individual mitotic abnormalities were scored by 
α-tubulin staining and counterstaining with DAPI. Only the data for anaphase and telophase abnormalities are shown. The data are derived 
from three independent experiments for each of the three donors, with a minimum of 100 abnormal mitotic cells scored for each experiment, 
and the data is shown as the mean (± standard error of the mean). The differences in the frequency of individual abnormalities between WT 
and E6ΔPDZ cells were not statistically significant. D. The frequency of the combined late (anaphase and telophase) mitotic abnormalities 
in the E6ΔPDZ genome containing cells shown relative to cells harboring the WT genomes. Student’s t test was used to determine the 
significance (*, P<0.05).
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Figure 4: Increased micronuclei formation associated with E6ΔPDZ genome-containing cells. A. The proportion of cells 
containing micronuclei was scored from DAPI-stained cells. The data were collected from three independent experiments, with a minimum 
of 200 cells for each donor scored on each occasion. The data are shown as the mean (± standard error of the mean), and in all three 
donors the frequency was increased in E6ΔPDZ genome-containing cells (*, p<0.05); ns, not significant). B. Images of examples of 
CENPA positive and negative nuclei; in overlay CENPA (green), nuclei (blue). C. The proportion of cells with micronuclei containing 
centromeres was determined by immunofluorescence staining for CENPA. The data were collected from three independent experiments, 
with a minimum of 200 cells with micronuclei scored for each experiment, and shown as the mean (± standard error of the mean).
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WT and E6ΔPDZ genome-containing cells the majority 
of micronuclei were CENPA–positive and this was 
consistent across the three different donor backgrounds, 
with no significant difference in the frequencies of the two 
populations between the different viral genomes (Figure 
4C). These data indicate that the formation of micronuclei 
in WT or mutant genome-containing cells occurs through 
similar mechanisms, although this is enhanced in the 
absence of the E6 PBM function. Moreover, since the 
majority of micronuclei formed in HPV-containing cells 
did not contain acentric chromosomes, this suggests that 
these micronuclei arise from chromosome segregation 
errors, in support of our previous data (Figure 3).
Increased aneuploidy of cells containing 
E6ΔPDZ genomes
Both numerical and structural chromosomal 
abnormalities are a frequent feature of HPV oncoprotein 
expressing cells; and the expression of both E6 and E7 
proteins induce mitotic abnormalities in keratinocytes [31, 
33]. If, as our data indicate, the loss of the PDZ binding 
function of E6 causes an increase in abnormal cells in 
anaphase and telophase, and elevated levels of micronuclei 
formation, then this would lead to an increase in the 
frequency of chromosomal abnormalities. To examine this 
hypothesis, interphase fluorescence in situ hybridization 
(FISH) using two chromosome-specific centromeric 
probes against chromosomes 10 and 12 was performed 
on cells harboring WT or mutant E6ΔPDZ genomes. 
For each cell line, three cell passages were investigated 
(approximately 16 - 24 population doublings between the 
first and third passages tested). Importantly, since extended 
cell culture of E6ΔPDZ cell lines often leads to loss of 
episomes and viral DNA integration, only cell passages 
prior to these viral genetic events (as determined by 
Southern analysis [27]) were subjected to FISH analysis.
Figure 5 shows the distribution of diploid and non-
diploid chromosome copy number in interphase cells 
from the three cell passages of both WT and E6ΔPDZ 
Figure 5: Increased aneuploidy of E6ΔPDZ genome-containing cells. Interphase fluorescence in situ hybridization using 
centromere enumeration probes for chromosomes 10 and 12. The data were collected from three different cell passages, with a minimum 
of 200 cells with single nuclei scored for each cell passage and given as the percentage of nuclei with diploid or non-diploid chromosome 
copy number (mean ± standard error of the mean). The statistical significance of the increase in non-diploid copy number was: donor#1, ns; 
donor#2, p<0.01 for chromosome 10 and 12; donor#3, p<0.01 for chromosome 10 and p<0.05 for chromosome 12.
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genome-containing cells. In comparison to WT genome 
carrying cells, there was an increase in the frequency of 
E6ΔPDZ cells with a non-diploid genome content and this 
was observed across the three donor backgrounds (Figure 
5). The level of increase in aneuploidy is statistically 
significant in two of the donors (donor #2, p<0.01 for both 
chromosomes probes; donor #3, p<0.01 for chromosome 
10 and p<0.05 for chromosome 12). Whilst the frequency 
of E6ΔPDZ cells with non-diploid chromosome content 
is increased in all donors, it is markedly enhanced in 
one of the donors (donor #2), by 8.4-fold (chromosome 
10) and 10.0-fold (chromosome 12) compared to WT 
cells, suggesting donor-specific variation. There was no 
marked change in the frequency of cells with non-diploid 
chromosome copy number upon population-doubling of 
all the cell lines (i.e. comparison between the first and 
third cell passages, data not shown). Both loss and gain 
of chromosome copy number occurred in the presence 
of WT and E6ΔPDZ genomes. However, the prevailing 
trend across all three donors was increased frequency of 
cells with >4 chromosome copy number in cells carrying 
the mutant HPV18 genome defective in PDZ targeting 
(Table 1).
Loss of E6-PDZ binding correlates with a change 
in the distribution of mitotic cells between the 
basal and suprabasal layers of organotypic raft 
cultures
We have previously shown that upon organotypic 
raft growth, the stratified cultures containing the 
E6ΔPDZ mutant genome showed decreased hyperplastic 
morphology relative to the WT genomes; they do not show 
the characteristic thickening associated with replication of 
WT genomes and there was a reduction in expansion of 
S phase-competent cells in the upper suprabasal layers 
[27]. Since our data thus far suggest that replication of 
the E6ΔPDZ mutant genomes is associated with mitotic 
abnormalities linked to spindle defects, we next wanted 
to determine if mitotic defects also occurred upon 
stratification of the E6ΔPDZ genome-containing cells, 
using α-tubulin staining to identify mitotic cells in sections 
of the organotypic rafts.
In organotypic rafts of untransfected keratinocytes, 
few cells undergo mitosis and these are always restricted 
to the basal layers (Figure 6A). In contrast, mitotic cells 
showing α-tubulin staining of the spindle were present 
in both the basal and suprabasal layers of rafts generated 
from the WT (Figure 6B, panels i, ii and iv) and the 
E6ΔPDZ (Figure 6C, panels i – iii) genome-containing 
cells. However, the majority of mitotic WT cells were 
observed in the suprabasal compartment (basal, 20%; 
suprabasal 80%), consistent with the expansion of these 
epithelial layers (Figure 6D), whereas in rafts generated 
from cells harboring the E6ΔPDZ genomes, a significantly 
(p<0.01) greater proportion of mitotic cells remained in 
the basal layer compared to the WT raft cultures (basal, 
71%; suprabasal 29%, Figure 6D). In the WT genome 
containing rafts, where polarity of the spindle was evident, 
it was most often bipolar (Figure 6B, panels i, ii and iv), 
although occasional cells with multipolar spindles were 
present (Figure 6B, panel iii). Interestingly, the polarity of 
the spindle could often not be determined in the E6ΔPDZ 
raft cultures, and where two poles were visible these were 
abnormal in appearance (Figure 6C, panel iii). Moreover, 
multipolar mitoses were present in E6ΔPDZ rafts (Figure 
6C, panels iv and v).
HR-HPV driven host genomic instability has been 
linked also to the induction of centrosome abnormalities 
by the viral oncoproteins [34, 35]. Significantly, abnormal 
centrosome amplification is observed in stratified cultures 
of HPV16 episome-containing cells, indicating that this 
centrosome defect occurs during the normal replication 
cycle of the virus [30]. Thus, we sought to determine 
if centrosome amplification occurred in stratified cells 
harboring the HPV18 genomes by staining raft sections 
with γ-tubulin to visualize the centrosomes. The number of 
centrosomes in centrosome-positive cells was scored and 
cells with >2 centrosomes were quantified (Figure 6E). 
In the presence of WT genomes there was a significant 
increase in cells containing >2 centrosomes compared 
to the untransfected donor keratinocytes (17.24% WT vs 
8.79% HFK). Notably, these data concur with the findings 
derived from HPV16 genome-containing rafts [30]. A 
similar proportion of cells (14.73%) with >2 centrosomes 
occurred in the stratified cultures of E6ΔPDZ genome-
Table 1: Relative fold change in chromosome copy number in E6ΔPDZ genome-containing cells compared to cells 
harboring WT genomes
Donor Chromosome Copy number loss Copy number gain Copy number gain >4
# 1 10
12
4.6
0.7
1.3
2.0
2.1
2.6
# 2 10
12
0.9
1.1
9.8
11.4
24.3
69.4
# 3 10
12
1.6
1.7
1.9
1.9
6.5
1.8
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Figure 6: Loss of E6 PBM function is associated with an alteration in the distribution of α-tubulin stained mitotic 
cells between basal and surpabasal cell layers of organotypic rafts. Sections of organotypic raft cultures of A. untransfected 
HFK, B. HPV18 WT genome-containing cells and C. cells containing E6ΔPDZ genomes, were stained for α-tubulin (green), HPV18 E4 
(red), and DNA (blue). Examples given in B and C were taken from multiple donors. The dotted white line in A, B and C indicates the 
junction between the basal cell layer and fibroblast embedded collagen matrix. D. The distribution of mitotic cells between the basal and 
suprabasal cell layers of organotypic rafts shown as a percentage of total α-tubulin stained mitotic cells (± standard error of the mean). 
Data were collected from three donors, and for each donor five sections of organotypic raft were analyzed (full thickness and entire length). 
Numbers of α-tubulin stained mitotic cells counted were 47 (HFK), 525 (WT) and 230 (E6ΔPDZ). Student’s t test was used to determine 
significance (**, p<0.01). E. Sections were stained with γ-tubulin to visualize centrosomes and cells with visible centrosomes were scored 
for centrosome number. Rafts prepared from three different donors were analyzed; numbers of cells scored were: 1772 (HFK), 4022 (WT) 
and 2758 (E6ΔPDZ). Student’s t test was used to determine significance (**, p<0.01; ***, p<0.001). Shown are examples of cells in 
E6ΔPDZ, WT rafts with >2 centrosomes, and an HFK raft with 2 centrosomes (red, γ-tubulin; blue, DAPI). The E6PDZ centrosomes are 
shown enlarged in the inset and the dotted white line indicates the junction between the basal cell layer and fibroblast embedded collagen 
matrix. Scale, 10 μm (inset 18.5 μm).
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containing cells (Figure 6E). Thus, the exacerbation of 
mitotic dysregulation that we observe in HPV18 genome-
containing cells upon loss of the E6 PDZ binding function 
is independent of the virus-induced effects upon the 
centrosomes.
DISCUSSION
Our study has investigated the role of the E6 PBM in 
a physiologically significant HPV life cycle model based 
on primary human epidermal keratinocytes harboring 
episomal forms of the HPV18 genome [27, 36]. We have 
shown that a population of the keratinocytes harbouring 
the HR-HPV episomes undergo abnormal mitosis and that 
the size of this population increased upon loss of the four 
amino acids that constitute the HPV18 E6 PBM. In the 
presence of the WT genomes, the majority of cells that 
undergo abnormal mitosis exhibited metaphase associated 
spindle defects, as determined by α–tubulin-staining, 
and very few cells with spindle–associated abnormalities 
were found to be in the mitotic late phases of anaphase or 
telophase. This suggests that in viral episome-containing 
cells, only a minor proportion of cells with metaphase 
spindle deformity can bypass the metaphase – anaphase 
checkpoint and thus exit into anaphase and telophase. 
These data are consistent with findings in cells expressing 
only the HPV16 E6 and E7 oncoproteins, where both E6 
and E7 functions contribute to the induction of mitotic 
spindle abnormalities, including multipolar spindles, 
chromosome misalignment and lagging chromosomes 
[31]. The defects described are associated with inactivation 
of the mitotic spindle assembly checkpoint that ensures 
engagement of all kinetochores with the spindle prior to 
progression through to anaphase. The role of HPV16 E6 
in the modulation of this checkpoint has been studied and 
associated with both p53-dependent and -independent 
pathways [32, 33, 37]. Notably, our data indicate that 
slippage through the metaphase-anaphase checkpoint is 
enhanced in the absence of the E6 PBM since a greater 
proportion of cells with abnormal spindle-associated 
defects are in anaphase and telophase. Thus, these data 
offer an explanation of the p53-independent effects 
previously observed.
It is well established that the E6 oncoprotein can 
disturb mitotic progression by interfering with multiple 
mitotic checkpoints [38]. The multinucleation of human 
keratinocytes co-expressing HPV16 E6 and E7 has been 
attributed to E6 oncoprotein function [35, 39], in complete 
agreement with our findings. Failure to protect E6-
expressing cells from defective cytokinesis and therefore 
from becoming multinucleate is linked to p53 inactivation 
[34, 39], but our data show that loss of the E6 PBM 
further perturbs mitotic division of episome–containing 
cells. In addition to causing an increase in the frequency 
of multinucleate cells, loss of the E6 PBM function also 
induces an increase in the degree of multinucleation of 
the cells, suggesting that the viability of multinucleate 
cells containing E6ΔPDZ genomes is greater than that of 
similar cells harboring WT genomes [35].
Our findings raise the interesting notion that the 
function of the E6 PBM of HPV18 acts to safeguard 
mitotic integrity in HPV-infected cells. Preserving 
mitotic integrity of viral genome-containing cells would 
be necessary to generate viable progeny, in which viral 
genomes can stably segregate between daughter cells and 
be maintained, as well as to support viral replication and 
promote persistence of episomes. This hypothesis would 
be consistent with our previous data demonstrating that 
HPV18 E6ΔPDZ genome-containing cells lose episomes 
after extended cell passage, and are unable to support 
efficient viral genome establishment or viral DNA 
amplification upon stratification [27]. Moreover, loss 
of episomal maintenance also occurs in keratinocytes 
harboring HPV16 and 31 genomes that express a mutant 
E6 protein unable to target PDZ proteins [28, 40]. 
Interestingly, it has recently been shown that maintenance 
replication of the mutant HPV16 E6ΔPDZ genomes could 
be partially restored in immortalized keratinocytes by 
repression of p53 protein expression [41]. The mechanism 
was not disclosed, but the authors hypothesized that 
the E6 PBM promotes viral genome maintenance by 
neutralization of a p53 activity that is resistant to E6-
mediated degradation. These findings imply that the 
balance between E6 functions in infected cells is important 
for episomal maintenance and future studies should be 
directed to understanding the p53-PDZ protein axis in 
the HR-HPV life cycle. Moreover, a balance between E6 
and E7 functions has also been shown to be important 
for episomal maintenance in primary keratinocytes [42]. 
Therefore, it cannot be ruled out that the role of the E6 
PBM might also function to mediate interactions with 
other HPV proteins, either directly or indirectly.
Disentangling the E6 PBM function in terms of 
specific PDZ targets is complicated by the very large 
number of PDZ proteins that have been identified to 
interact with E6 via the PBM [43, 44]. Many of these 
PDZ substrates are degraded by E6 via the proteasome, 
or have altered cellular localization in HPV positive 
cervical cancer cells. However, our own analyses have not 
identified similar effects on specific E6 PDZ substrates 
in the context of cells harboring complete HR-HPV 
genomes [45], and similar observations have been made 
in overexpression studies (either E6 expressed alone or 
together with E7) in epidermal keratinocytes of transgenic 
mice or in primary foreskin keratinocytes in cell culture 
[46, 47]. Furthermore, the interaction between E6 and 
PDZ proteins is most likely tightly regulated during the 
virus life cycle by phosphorylation of the E6 motif [18, 
27]. Phosphorylation of the PBM blocks the interaction 
with PDZ proteins and enables E6 interaction with 
isoforms of the 14-3-3 proteins [18, 19, 44]. The E6ΔPDZ 
mutant is unable to interact with PDZ or 14-3-3 proteins. 
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However, cells harboring a HPV18 mutant genome 
containing an E6 mutation that abrogates phosphorylation 
of the E6 PBM, thus blocking interaction with 14-3-
3 isoforms, but confers constitutive targeting of PDZ 
proteins, retain stable replication of the viral episomes and 
support vegetative genome amplification [27]. Thus, this 
strongly indicates that the underlying mechanism of the E6 
mitotic function described here involves targeting of PDZ 
proteins. Nevertheless, it remains to be determined what 
specific PDZ protein(s) may function to maintain mitotic 
and genomic stability.
In normal epithelia, asymmetric cell division of the 
basal cells is required for normal differentiation; producing 
two daughter cells with dissimilar fates of proliferation 
and differentiation. This process can become uncoupled, as 
in the developing mouse epidermis, where differentiating 
suprabasal daughter cells from basal mitotic divisions 
retain mitotic potential in order to rapidly form the multi-
layered epidermis [48]. The orientation of the mitotic 
spindle has an important role to play in the symmetry 
of cell division; the polarity complexes Par and Scribble 
that contain several of the E6 PBM substrates, including 
DLG1 and hScrib, and the 14-3-3 proteins, have important 
roles in directing the positioning of the mitotic spindle in 
Drosophila epithelial cells [49–51]. Moreover, some of the 
products of the mammalian homologues of these genes, 
including the PDZ protein PAR3, are also involved in 
directing spindle orientation in the developing embryonic 
mouse epidermis [48]. Notably, disturbance of mitotic 
spindle polarity in the mouse epidermis led to epidermal 
hyperproliferation and suprabasal mitoses [48, 52]. In our 
previous study, we showed that disruption of the E6 PBM 
was linked to a reduction in the expansion of replication 
competent cells in the upper layers of organotypic rafts 
[27]. In support of this, we show here that whilst in the WT 
cells the majority of mitotic cells reside in the suprabasal 
layers, the converse occurs in the mutant E6ΔPDZ rafts, 
where the basal layer contains the majority of mitotic 
cells. Moreover, our data demonstrate that loss of the E6 
PBM may perturb orientation of the mitotic spindle on 
organotypic raft culture, and leads to spindle defects in 
anaphase and telophase. One explanation for this is that 
in infected epithelia, HPV disturbs the polarity of mitotic 
cells to allow rapid suprabasal expansion, and the E6 PBM 
somehow contributes to the deregulation of pathways that 
control this polarity. Interestingly, E7 associates with the 
spindle protein nuclear mitotic apparatus protein [53], 
which is important for spindle positioning in asymmetric 
cell divisions [48], suggesting that both E6 and E7 may 
cooperate to alter mitotic cell polarity and this is necessary 
for viral persistence and vegetative replication.
The nature of the E6 PBM interaction with PDZ 
domains makes it an amenable peptide-protein interaction 
for inhibition by small molecules with the intention to 
develop novel therapeutics for the treatment of HPV–
associated cancers [54, 55]. Since the E6 PBM is essential 
for viral replication [27], inhibition of this function may 
be considered a route of anti-viral intervention to treat 
active infections. However, the data presented here offers 
a note of caution to disturbing the E6 PBM function in 
viral genome-containing cells. Firstly, loss of this function 
in this context is associated with viral DNA integration 
[28, 29], and this is a known risk factor for progression 
of HR-HPV infections to malignancy. In addition, we 
have demonstrated that viral episome-containing cells 
that have lost the E6 PBM function show increased 
genome instability in comparison to cells carrying the 
WT genomes. Thus, targeting this virus-host interaction 
therapeutically may instead accelerate the progression of 
HPV infections to malignancy. Also, it is worth noting 
that modulation of the PKA or AKT signaling pathways 
that lead to phosphorylation of the E6 PBM could be 
an independent risk factor for malignant progression by 
blocking E6 PDZ interactions [19, 27, 56].
Finally, this study suggests that one role of the E6 
PBM in the HPV life cycle is to maintain mitotic viability 
of episome-containing cells, ultimately protecting the 
cells and permitting viral persistence. However, this E6 
motif also prevents the cells from acquiring host genome 
instability and aneuploidy, both of which are associated 
with oncogenicity. Since the E6 PBM has been associated 
with acquisition of malignant phenotypes associated with 
the late stage of carcinogenesis [13, 14], this E6 function 
therefore has both tumor suppressor and oncogenic roles, 
dependent on the cellular context.
MATERIALS AND METHODS
Cell culture and generation of HPV18 genome-
containing cells
Primary human foreskin keratinocytes (HFK) were 
isolated from new-born foreskin circumcision tissue 
samples collected from patients attending a general 
practitioner’s practice, with informed written parental 
consent (Southampton and South West Hampshire research 
ethics committee A approval no. 06/Q1702/45). The cells 
were maintained in serum free media (SFM keratinocyte 
growth media, Life Technologies, Paisley, United 
Kingdom) as previously described [57]. Low passage 
fibroblasts (J2-3T3) were maintained in Dulbecco’s 
modified media supplemented with 10% bovine serum 
(Gibco, Thermo Fisher Scientific, Cramlington, United 
Kingdom) and 4 mM L-glutamine.
HFK from three different donors (#1, #2, #3) were 
each transfected with the recircularized wild type (WT) 
and mutant (E6ΔPDZ) HPV18 genomes and episome-
containing cell lines established, as described previously 
[27, 36]. Briefly, following transfection, cells were plated 
onto a feeder layer of γ-irradiated J2-3T3 fibroblasts 
(3,000 rads) in E media containing fetal calf serum 
(HyClone, Thermo Fischer Scientific), epidermal growth 
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factor (BD Biosciences, Oxford, United Kingdom) and 
G418 antibiotic (PAA laboratories, Yeovil, UK) [36]. 
The cells were maintained under drug selection for 8 
days and henceforth grown in E medium without G418 
antibiotic. Once cell colonies emerged, they were pooled 
and expanded on a fibroblast feeder layer. Presence of 
viral episomes in the HPV18 genome transfected cells 
lines was confirmed by Southern analysis of total DNA 
extracted from the monolayer grown cells using a [α-32P] 
dCTP-labelled HPV18 genomic probe as described 
previously [36].
Live cell microscopy
Real-time images of cell growth on plastic were 
captured by a Cell-IQ system (CM Technologies) running 
Imagen software version 2.8.12.0 and analyzer version 
3.3.0. Cells were seeded at a density of 2 × 104 cells 
onto a feeder layer of γ-irradiated J2-3T3 fibroblast cells 
in a twelve-well plate, and grown in complete E media 
(replaced every two days), until cell colonies were visible. 
The plate was then inserted into the Cell-IQ, and between 
three and five locations within each well were monitored 
every 7 min over a 16 h period at 10x magnification, in 
5% CO2 at 37°C.
Mitotic events were scored from the resulting time-
lapse videos as ‘normal’ (based upon: bipolar, visible 
and equal separation and timing of mitosis) or otherwise 
‘abnormal’. For each cell line, between 14 and 23 colonies 
were counted, with every mitotic event within that colony 
scored, equating to 90 to 308 mitoses per cell line.
Organotypic raft culture
Organotypic raft cultures were grown at the 
air-liquid interface for 13 days and fixed with 3.7% 
formaldehyde, as described previously [58]. Rafts were 
paraffin-embedded and 4 μm sections prepared (Propath 
UK, Ltd., Hereford, United Kingdom).
Phase contrast and immunofluorescence 
microscopy
Keratinocytes were grown on γ-irradiated J2-3T3 
cells seeded into wells of a six multi-well plate and viewed 
by phase contrast on Axiovert 100 microscope (Zeiss). For 
immunofluorescence microscopy, cells were grown on 
γ-irradiated J2-3T3 cells seeded onto glass coverslips. Once 
the keratinocytes had reached 60% confluence, the feeder 
cells were removed with EDTA in phosphate-buffered saline 
(PBS) and the cells were fixed in 3.6% formaldehyde (EM-
Grade, TAAB laboratories, Aldermaston, Berks, United 
Kingdom) for 20 min and then permeabilized using 0.1% 
Triton X-100 for 5 min. Fixed cells were pretreated with 
blocking buffer (20% v/v heat-inactivated normal goat 
serum, 0.1% w/v bovine serum albumin in PBS) prior to 
addition of anti-α-tubulin antibody at 1 in 2000 dilution 
(clone B512, Sigma-Aldrich) or anti-CENPA antibody at 1 
in 500 dilution (3-19, Abcam, Cambridge, United Kingdom). 
Immune complexes were recognized by an anti-mouse Alexa 
488 conjugate (Molecular Probes, Life Technologies). For 
staining of organotypic rafts, sections (4 μm) were first 
de-paraffinized and subjected to low-temperature antigen 
retrieval as described by us previously [59]. Sections were 
then incubated with blocking buffer followed by staining 
with antibodies to α-tubulin and HPV18 E4 antibody 
R424 [60], and γ-tubulin at 1 in 500 dilution (mouse 
monoclonal antibody, Abcam), and immune complexes 
detected using anti-mouse Alexa 488 or 594, and anti-rabbit 
Alexa 594 conjugates. Nuclei were counterstained with 4’, 
6’-diamidino-2-phenylindole (DAPI), and cells and raft 
sections mounted in ProLong® Gold Antifade reagent (Life 
Technologies). Stained cells and sections were viewed on a 
Nikon Eclipse E600 microscope fitted with epifluorescence.
Interphase fluorescence in situ hybridization
Cell suspensions were harvested after 15 min 
treatment with hypotonic solution (0.075 M KCl) prior to 
methanol:acetic acid (3:1 v/v) fixation and then the cells 
were dropped onto clean glass slides. CEP10 and CEP12 
probes (Cytocell, Cambridge, United Kingdom) were 
applied to the slides under a coverslip and hybridized 
overnight on a HYBrite (Abbott Molecular, Maidenhaed, 
United Kingdom). Slides were then washed in a solution 
containing the DNA stain DAPI (Cytocell, Cambridge, 
United Kingdom) and for each cell passage, at least 200 
cells with single nuclei visualized.
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